HIF1A and breast carcinoma: In relapse-free survival (RFS), overall survival (OS), distant metastasis-free survival (DMFS), and post-progression survival (PPS) analyses, high mRNA levels of HIF-1α were associated with lower survival rates in patients with breast carcinoma (Fig. 7C).